Vandana Madkan, MD
Dermatology · Sugar Land, TXNPI 1659691772
Payments from drug & device makers
Across 1,007 payments — averaging $1832.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$743K
- Eli Lilly$662K
- Amgen$163K
- AbbVie$134K
- Bausch Health US, LLC$57K
- Bristol Myers Squibb$43K
- plus $43K from 21 others
Across 14 payments — averaging $3171.10 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$43K
- Sanofi US Services Inc.$1K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 213 | $742,747 |
| Eli Lilly | 10 | $662,366 |
| Amgen | 156 | $162,892 |
| AbbVie(2 entities) | 174 | $134,103 |
| Bausch Health US, LLC | 16 | $56,883 |
| Bristol Myers Squibb | 42 | $42,579 |
| Incyte Corporation | 44 | $20,628 |
| Novartis | 50 | $5,463 |
| Dermavant Sciences, Inc. | 28 | $4,286 |
| Arcutis Biotherapeutics, Inc. | 24 | $3,192 |
| Sun Pharmaceutical Industries Inc. | 24 | $3,079 |
| Organon | 16 | $1,299 |
| Johnson & Johnson | 41 | $1,109 |
| E.r. Squibb & Sons, L.L.C. | 38 | $748 |
| Regeneron Healthcare Solutions, Inc. | 24 | $613 |
| Galderma Laboratories, L.p. | 18 | $538 |
| UCB, Inc. | 15 | $533 |
| Lilly USA, LLC | 24 | $482 |
| LEO Pharma Inc. | 14 | $387 |
| Sanofi | 14 | $348 |
| VYNE Pharmaceuticals Inc. | 2 | $163 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 9 | $155 |
| Springworks Therapeutics, Inc. | 3 | $77 |
| Boehringer Ingelheim | 3 | $75 |
| Medline Industries LP | 1 | $29 |
| Biofrontera Inc. | 2 | $28 |
| Kyowa Kirin, Inc. | 2 | $28 |
How this compares
$1,844,833 in reported general payments places this provider in the 95th percentile of 1,098 dermatology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other dermatology in Sugar Land
- Stephen TyringWebster$14.1M
- Edward LainAustin$12M
- Mark LeeSan Antonio$10.9M
- John BrowningSan Antonio$10.7M
- Craig TellerBellaire$7.7M
- Patricia LeeWebster$7.2M
- Jennifer CatherDallas$4.9M
- Michael MigdenHouston$3.7M
- Martin MenterDallas$3.7M
- Janet DuboisAustin$3.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.